Latest Insights on F
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Your Coronavirus Crisis Plan: Watch for This Rally February 3, 2020 Global Economy, Investment Opportunities, Winning Investor Daily
The coronavirus outbreak is setting up a huge rally for the rest of the year — and you won’t want to miss out.
What the Latest Earnings Reports Really Tell Us About Amazon, Tesla and the S&P 500 February 3, 2020 Big Picture. Big Profits., Investing, News, Stocks
[15-minute video] How the latest outbreak will impact certain stocks.
Coronavirus Alert — Grab Double-Digit Gains When Stocks Rebound February 3, 2020 American Investor Today, Natural Resources
The coronavirus is spreading faster than the SARS outbreak in 2003. Markets are falling on fear of a global slowdown. But quick action from world leaders is helping contain the virus. Matt Badiali shares a contrarian strategy for buying great stocks at discounted prices.
Take Our Super Bowl Survey Now! February 2, 2020 Winning Investor Daily
Sunday night is the Super Bowl! Let us know what you think by taking this three-question now.MEET OUR EXPERTS
Director of VIP Services
Chief Investment Strategist of Money & Markets
Research Analyst
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
